A warning on Biogen
Idec and Elan Corp's drug, Tysabri, has been revised following two recent reports of a potentially fatal brain infection, Biogen said. The company plans to provide an update on the two patients on today at a medical conference in Madrid, Biogen spokeswoman Shannon Altimari also said. Still, both companies were down sharply since they disclosed on July 31 that two ...